GLMD is Galmed Pharmaceuticals Ltd. — a non-dividend-paying stock. Trading at $3.88. Market cap: $4M. Capital Quality Rank: 6/100 — Systemic risk.
Stock snapshot
| Price | $3.88 |
| Market cap | $4M |
| Sector | — |
| Exchange | XNAS |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 6 / 100 · Systemic risk |
| ROIC (TTM) | -40.8% |
| Shareholder buyback yield | -30.00% |
| Altman Z-score zone | Distress |
About GLMD
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.
Frequently asked
What is GLMD's current stock price?
GLMD (Galmed Pharmaceuticals Ltd.) is currently trading at $3.88.
Does GLMD pay a dividend?
GLMD (Galmed Pharmaceuticals Ltd.) does not currently pay a regular dividend.
What is GLMD's Capital Quality Rank?
GLMD has a Capital Quality Rank of 6/100 — Systemic risk. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track GLMD in DiviDrip
Add GLMD to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search GLMD and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.